BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND ERCC5, XPGC, 2073, ENSG00000134899, RP11-484I6_5, COFS3, XPG, UVDR, ERCM2 AND Staging
1107 results:

  • 1. [Clinical analysis of 12 cases of ovarian yolk sac tumor].
    Liu J; Chu HJ; Shan YP; Song WJ; Chen AP
    Zhonghua Fu Chan Ke Za Zhi; 2024 Mar; 59(3):210-214. PubMed ID: 38544450
    [No Abstract]    [Full Text] [Related]  

  • 2. Sentinel Node Mapping in ovarian Tumors: A Study Using Lymphoscintigraphy and SPECT/CT.
    Ataei Nakhaei S; Sadeghi R; Mostafavi SM; Treglia G; Hassanzadeh M; Esmaeilpour M; Taheri NS; Farazestanian M
    Contrast Media Mol Imaging; 2024; 2024():5453692. PubMed ID: 38435483
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Laparoscopic versus laparotomic surgical treatment in apparent stage I ovarian cancer: a multi-center retrospective cohort study.
    Zhang J; Li M; Feng L; Zhai Y; Wang L; Chen Y
    World J Surg Oncol; 2024 Feb; 22(1):62. PubMed ID: 38389046
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The significance of lower uterine segment involvement in endometrial cancer.
    Davidesko S; Meirovitz M; Shaco-Levy R; Yarza S; Samueli B; Kezerle Y; Kessous R
    Eur J Surg Oncol; 2024 Mar; 50(3):108007. PubMed ID: 38382274
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Differentiation of survival outcomes by anatomic involvement and histology with the revised 2023 International Federation of Gynecology and Obstetrics staging system for endometrial cancer.
    Gravbrot N; Weil CR; DeCesaris CM; Gaffney DK; Suneja G; Burt LM
    Eur J Cancer; 2024 Apr; 201():113913. PubMed ID: 38377777
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinicopathological pattern of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 over-expression of epithelial ovarian carcinomas in Nigeria.
    Ajani MA; Lawan A; Oke T; Khramtsova G; Nwanji I; Salami A; Awolude O; Ebili H; Onwukamuche ME; Sveen E; Yoshimatsu T; Olopade OI
    Afr Health Sci; 2023 Sep; 23(3):236-244. PubMed ID: 38357171
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Is minimally invasive surgical approach a reasonable option in apparent early stage epithelial ovarian cancer restaging? Results from a multicentric retrospective study.
    Mokarram Dorri N; Del M; Cannone F; Lefebvre M; Loaec C; Sabiani L; Jauffret C; Blache G; Houvenaeghel G; Carcopino X; Classe JM; Narducci F; Martinez A; Lambaudie E
    Eur J Surg Oncol; 2024 Mar; 50(3):107976. PubMed ID: 38354484
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. BRCA1, BRCA2, and TP53 germline and somatic variants and clinicopathological characteristics of Brazilian patients with epithelial ovarian cancer.
    Richau CS; Scherer NM; Matta BP; de Armas EM; de Barros Moreira FC; Bergmann A; Pereira Chaves CB; Boroni M; Dos Santos ACE; Moreira MAM
    Cancer Med; 2024 Feb; 13(3):e6729. PubMed ID: 38308422
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Is routine gastrointestinal endoscopy required in every woman with mucinous ovarian cancer? An analysis of survival rates and metastatic tumours in a cancer centre.
    Katsanevakis E; Addo-Yobo W; Bharathan B; Loona A; Gan C; Nunns D; Gajjar K
    Eur J Obstet Gynecol Reprod Biol; 2024 Mar; 294():105-110. PubMed ID: 38237307
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Survival outcomes of epithelial ovarian cancer treated at a tertiary-level hospital in India.
    Chandy RG; Thomas V; Sebastian A; Mani T; Thomas A; Joel A; Ram TS; Peedicayil A
    Indian J Cancer; 2023 Oct; 60(4):475-485. PubMed ID: 38185864
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Reproductive outcomes after conservative treatment in early and advanced stage MOGCTs.
    Vasta FM; Cormio G; Cassani C; Bergamini A; Scarfone G; Ferrandina G; De Vivo R; Marinaccio M; Danese S; Raspagliesi F; Pignata S; Mangili G
    Gynecol Oncol; 2024 Feb; 181():28-32. PubMed ID: 38104526
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Effects of epidural anesthesia on the prognosis of ovarian cancer-a systematic review and meta-analysis.
    Shen H; Pang Q; Gao Y; Liu H
    BMC Anesthesiol; 2023 Nov; 23(1):390. PubMed ID: 38030996
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Oncologic outcomes of robot-assisted laparoscopy versus conventional laparoscopy for the treatment of apparent early-stage endometrioid adenocarcinoma of the uterus.
    Lim YH; Dagher C; Abu-Rustum NR; Mueller JJ; Sonoda Y; Zivanovic O; Broach V; Leitao MM
    Gynecol Oncol; 2023 Dec; 179():152-157. PubMed ID: 37980770
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Mapping sentinel lymph nodes in early-stage ovarian cancer (MELISA) trial - a further step towards lymphadenectomy replacement.
    Agustí N; Vidal-Sicart S; Paredes P; Celada-Castro C; Migliorelli F; Glickman A; Marina T; Fusté P; Carreras-Dieguez N; Saco A; Díaz-Feijóo B; Torné A
    Gynecol Oncol; 2023 Dec; 179():145-151. PubMed ID: 37980769
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Lymph node staging in grade 1-2 endometrioid ovarian carcinoma apparently confined to the ovary: Is it worth?
    Bizzarri N; Imterat M; Fruscio R; Giannarelli D; Perrone AM; Mancari R; Traut A; Rosati A; du Bois A; Ferrari D; De Iaco P; Ergasti R; Ataseven B; Bianchi T; Di Stanislao M; Perri MT; Heitz F; Concin N; Fanfani F; Vizza E; Scambia G; Harter P; Fagotti A
    Eur J Cancer; 2023 Dec; 195():113398. PubMed ID: 37890354
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Nomogram incorporating log odds of positive lymph nodes improves prognostic prediction for ovarian serous carcinoma: a real-world retrospective cohort study.
    Zhang S; Liu X; Li Q; Pan Y; Tian Y; Gu X
    BMJ Open; 2023 Oct; 13(10):e074206. PubMed ID: 37865413
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Clinicopathological Features and Survival Trends of Non-Epithelial ovarian cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database.
    Zhang C; Xi X
    Oncol Res Treat; 2023; 46(11):476-492. PubMed ID: 37857263
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Study on the predictive significance of PLR, SII and RPR in ovarian endometriotic cyst].
    Li MM; Tang XH; Wang LM
    Zhonghua Fu Chan Ke Za Zhi; 2023 Sep; 58(9):672-679. PubMed ID: 37724384
    [No Abstract]    [Full Text] [Related]  

  • 19. Recurrence Risk Stratification for Women With FIGO Stage I Uterine Endometrioid Carcinoma Who Underwent Surgical Lymph Node Evaluation.
    Ghanem AI; Bhatnagar A; Elshaikh M; Hijaz M; Elshaikh MA
    Am J Clin Oncol; 2023 Dec; 46(12):537-542. PubMed ID: 37679878
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Robotic surgery in ovarian cancer.
    Gallotta V; Certelli C; Oliva R; Rosati A; Federico A; Loverro M; Lodoli C; Foschi N; Lathouras K; Fagotti A; Scambia G
    Best Pract Res Clin Obstet Gynaecol; 2023 Aug; 90():102391. PubMed ID: 37573801
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 56.